News from CNBC Business

All U.S. UK Canada Australia India Global Global (Crypto)

What is your interest today?

Bitcoin Crypto Btc Ceo Tariffs Stocks Crypto Assets Investors Cryptocurrency Shares Stock Stock Market Ethereum Price Markets Xrp Investment Blockchain Etf Stablecoin Sec Eth Trade Bse Index Earnings Ipo Revenue Solana China Coinbase Token Inflation Wall Street Nasdaq Interest Rates Sensex Trade War Usd Economy Tesla Nse Profit Traders Gold Digital Assets Bse Sensex Sp 500 Treasury Federal Reserve Levies Automation Mansion Ai Investment Sport Sponsorship Deposit Book Bounty Gaming Startup Trust Wallet Accommodation Costs

Filter by:

Merck × Past month × CNBC Business ×

CNBC Business • Jun 09, 2025

FDA approves Merck’s RSV shot for infants, ramping up competition with Sanofi and AstraZeneca

Merck’s newly authorized RSV vaccine for infants is expected to impact the market by challenging established treatments, potentially influencing sales and market share among leadin...

Read Full Article →